ADAM19 is essential for normal cardiovascular morphogenesis in mice, suggesting its mutations may contribute to human congenital heart valve and septal defects.
Answers are grounded in this paper and cite their sources.
Mouse ADAM19 loss does not inform human care; hypothesis-generating for its role in congenital septal and valve defects.
Congenital heart disease is the most common form of human birth defects, yet much remains to be learned about its underlying causes. Here we report that mice lacking functional ADAM19 (mnemonic for a disintegrin and metalloprotease 19) exhibit severe defects in cardiac morphogenesis, including a ventricular septal defect (VSD), abnormal formation of the aortic and pulmonic valves, leading to valvular stenosis, and abnormalities of the cardiac vasculature. During mouse development, ADAM19 is highly expressed in the conotruncus and the endocardial cushion, structures that give rise to the affected heart valves and the membranous ventricular septum. ADAM19 is also highly expressed in osteoblast-like cells in the bone, yet it does not appear to be essential for bone growth and skeletal development. Most adam19(-/-) animals die perinatally, likely as a result of their cardiac defects. These findings raise the possibility that mutations in ADAM19 may contribute to human congenital heart valve and septal defects.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: